Strategies to reduce embryonic mortality in buffalo cows

The aim of the present study was to examine whether treatment with a GnRH agonist, hCG or P4 on Day 25 after AI increased P4 concentrations and reduced the incidence of embryonic mortality (EM) in pregnant buffaloes mated in mid-winter in a Mediterranean environment. The trial was carried out in two farms characterized, in previous years, by low (LEM Group), 153 buffaloes (DIM=150±7 days), and high (HEM Group), 284 buffaloes (DIM=163±5 days), incidence of embryo mortality. Animals were synchronized by Ovsynch-TAI Program and artificially inseminated. On day 25, pregnant buffaloes were randomly assigned to four groups: Control (no treatment), GnRH agonist (buserelin acetate, 12.6 μg), hCG (1500 IU) and P4 (341 mg of P4 i.m. every 4 days for three times). Progesterone (pg/ml) was determined in milk whey on Days 10, 20 and 25 after AI in all buffaloes and in Days 30 and 45 only in buffaloes pregnant on day 25 and assigned to four groups of treatment. Pregnancy diagnosis was undertaken on Day 45 by ultrasound. All treatments increased P4 milk whey and reduced embryonic mortality in buffalo cows bred in the farm characterized by high EM

embryonic mortality in buffalo naturally mated

The aim of this work was to evaluate the incidence of embryonic mortality in three different period of year in buffaloes naturally mated. The trial was carried out in a buffalo farm located in Caserta province between 2000-2006. In this period were registered natural insemination on 200 buffaloes. Pregnancy diagnosis was carried out on Day 30, confirmed on Day 45 and every 15th days until 90 days after natural mating. Buffaloes that were pregnant on Day 30 but not on Day 45 or Day 90 were considered to have undergone embryonic (EM) or fetal mortality (FM) respectively. EM and FM were 8.8% and 13.4% respectively throughout the experimental period. A high incidence (P<0.01) of FM was found in the transitional period (December-March) than in other months of the year. The incidence of embryonic mortality was significantly (P<0.01) higher between 28-60 days of gestation and lower after 71 day of gestation. The higher fetal mortality found in this study could be due the lower serum levels of progesterone normally found in transitional period in buffalo cows

Strategies to reduce embryonic mortality in buffalo cows

The aim of the present study was to examine whether treatment with a GnRH agonist, hCG or P on Day 25 after AI increased P concentrations and reduced the incidence of embryonic mortality (EM) in pregnant buffaloes mated in mid-winter in a Mediterranean environment. The trial was carried out in two farms characterized, in previous years, by low (LEM Group), 153 buffaloes (DIM=150±7 days), and high (HEM Group), 284 buffaloes (DIM=163±5 days), incidence of embryo mortality. Animals were synchronized by Ovsynch-TAI Program and artificially inseminated. On day 25, pregnant buffaloes were randomly assigned to four groups: Control (no treatment), GnRH agonist (buserelin acetate, 12.6 μg), hCG (1500 IU) and P (341 mg of P i.m. every 4 days for three times). Progesterone (pg/ml) was determined in milk whey on Days 10, 20 and 25 after AI in all buffaloes and in Days 30 and 45 only in buffaloes pregnant on day 25 and assigned to four groups of treatment. Pregnancy diagnosis was undertaken on Day 45 by ultrasound. All treatments increased P milk whey and reduced embryonic mortality in buffalo cows bred in the farm characterized by high EM

Embryonic mortality in buffalo naturally mated

The aim of this work was to evaluate the incidence of embryonic mortality in three different period of year in buffaloes naturally mated. The trial was carried out in a buffalo farm located in Caserta province between 2000-2006. In this period were registered natural insemination on 200 buffaloes. Pregnancy diagnosis was carried out on Day 30, confirmed on Day 45 and every 15 days until 90 days after natural mating. Buffaloes that were pregnant on Day 30 but not on Day 45 or Day 90 were considered to have undergone embryonic (EM) or fetal mortality (FM) respectively. EM and FM were 8.8% and 13.4% respectively throughout the experimental period. A high incidence (

Delayed treatment with GnRH agonist, hCG and progesterone and reduced embryonic mortality in buffaloes.

The present study examined the effect of delayed treatment with tropic hormones and progesterone (P4) on embryonic mortality in buffaloes. Buffaloes with a conceptus on Day 25 after AI were assigned to the following treatments: Control (n = 41), i.m. physiological saline; GnRH agonist (n = 36), i.m. 12 mg buserelin acetate; hCG (n = 33), i.m. 1500 IU hCG; P4 (n = 38), i.m. 341 mg P4 every 4 days on three occasions. Control buffaloes had an embryonic mortality of 41.4% (17/41) between Days 25 and 45, and this was reduced (P < 0.01) by treatment with GnRH agonist (11.1%, 4/36), hCG (9.0%, 3/33) and P4 (13.1%, 5/38). On Day 45, buffaloes treated with hCG and which ovulated had greater (P < 0.05) concentrations of P4 in whey (453 41 pg/ml) than buffaloes in the same treatment that did not ovulate (297 32 pg/ml). A similar but non-significant trend was observed for buffaloes treated with GnRH agonist. It was concluded from the findings that the treatment of buffaloes on Day 25 after AI with tropic hormones or P4 is beneficial to processes associated with embryonic implantation

Delayed treatment with GnRH agonist, hCG and progesterone and reduced embryonic mortality in buffaloes

The present study examined the effect of delayed treatment with tropic hormones and progesterone (P) on embryonic mortality in buffaloes. Buffaloes with a conceptus on Day 25 after AI were assigned to the following treatments: Control (n = 41), i.m. physiological saline; GnRH agonist (n = 36), i.m. 12 μg buserelin acetate; hCG (n = 33), i.m. 1500 IU hCG; P (n = 38), i.m. 341 mg P every 4 days on three occasions. Control buffaloes had an embryonic mortality of 41.4% (17/41) between Days 25 and 45, and this was reduced (P < 0.01) by treatment with GnRH agonist (11.1%, 4/36), hCG (9.0%, 3/33) and P (13.1%, 5/38). On Day 45, buffaloes treated with hCG and which ovulated had greater (P < 0.05) concentrations of P in whey (453 ± 41 pg/ml) than buffaloes in the same treatment that did not ovulate (297 ± 32 pg/ml). A similar but non-significant trend was observed for buffaloes treated with GnRH agonist. It was concluded from the findings that the treatment of buffaloes on Day 25 after AI with tropic hormones or P is beneficial to processes associated with embryonic implantation

Efeito do intervalo entre recrutamentos foliculares na superovulação de vacas da raça Holandesa não-lactantes Effect of interval between follicular recruitments on superovulatory response in non-lactanting Holstein cows

Vacas da raça Holandesa não-lactantes, distribuídas em dois grupos, foram sincronizadas com o protocolo Ovsynch modificado. No dia sete (dia 0 = dia do segundo GnRH), o grupo 7 (G-7; n=19) recebeu CIDR usado previamente por cinco dias e 100mcg de GnRH, e o grupo 14 (G-14; n=21), CIDR e 25mg de PGF2alfa. No dia 14 foi aspirado o folículo dominante (FD), trocado o CIDR usado por um novo e foram aplicados 25mg de PGF2alfa. Iniciou-se o tratamento com FSH 36h depois, removeu-se o CIDR com o sétimo FSH e aplicou-se GnRH 36h depois. As inseminações foram feitas 12 e 24h depois. Recuperaram-se os embriões sete dias depois da inseminação artificial. O diâmetro do FD no G-7 foi 13,1&plusmn;0,57mm no dia sete e 11,2&plusmn;0,57mm no dia 14. O diâmetro FD persistente no G-14 aumentou de 12,6&plusmn;0,55mm no dia sete para 16,4&plusmn;0,55mm no dia 14 (P<0,001). O número de folículos >8mm, 48h após o início do tratamento com FSH, foi maior (P<0,05) no G-7 (15,6&plusmn;0,05) que no G-14 (12,5&plusmn;0,05). Não foi detectado efeito de tratamento sobre o número de corpos lúteos e de embriões. O menor intervalo entre recrutamentos foliculares aumentou o número de folículos recrutados, porém não alterou a quantidade e a qualidade dos embriões produzidos.<br>Dry Holstein cows were synchronized by a modified Ovsynch protocol. On day 7 (day 0 = day of the second GnRH), group 7 (G-7; n=19) received an used CIDR and GnRH (100µg). Group 14 (G-14; n=21) received an used CIDR and PGF2alpha (25mg). On day 14, the dominant follicle (DF) was removed, by aspiration; the used CIDR was changed for a new CIDR plus PGF2alpha. Thirty-six hours later, the FSH treatment was initiated. On the seventh injection of FSH, the CIDR was removed. Thirty-six hours after, the cows received GnRH. Donors were inseminated 12 and 24h after the GnRH injection. Embryos were recovered seven days after AI. The DF diameter in G-7 was 13.1mm on day 7 and 11.2mm on day 14. The persistent DF in the G-14 increased from 12.6mm on day 7 to 16.4mm on day 14 (P<0.001). The number of follicles >8mm, 48h after the beginning of the FSH treatment, was 15.6 in G-7 and 12.5 in G-14 (P<0.05). No treatment effects were detected on number of corpus luteum and embryos. The shorter interval between follicular recruitment the higher the number of recruited follicles, but it did not have effects on the number or quality of embryos produced